Wisp Review: Sublingual Semaglutide Drops From a Platform With 1.8 Million Patients

What Is Wisp?

Wisp is a large direct-to-consumer telehealth platform best known for sexual and reproductive health — birth control, emergency contraception, UTI and STI care. It has extended into what it calls Weight Care, and the offering is narrower and more distinctive than most competitors.

Rather than a full menu of injectables, Wisp's flagship GLP-1 product is compounded sublingual semaglutide drops in a 15mL bottle at $225 per month. There is no compounded injectable line. Alongside it, Wisp sells Metabolic GLP Support Capsules at $54 per month and a standalone Weight Care Consult.

Scale is Wisp's strongest credential. The company states it is 'trusted by 1.8 million+ nationwide' and carries a 4.3 out of 5 company review rating. It advertises 100% online, board-certified medical providers, and states that if prescribed, treatment is sent same-day to your local pharmacy or delivered free and discreetly to your door.

One operational detail is worth knowing before you order: Wisp adds the lowest dosage of your chosen medication to your cart by default, with the provider reviewing and adjusting based on your medical history afterward. It is a product-first checkout flow with clinical review layered on.

Medications Offered & Pricing

Wisp's GLP-1 offering is narrow by design: compounded sublingual semaglutide is the only GLP-1 medication we found priced on its weight care pages. There is no compounded tirzepatide or injectable semaglutide line. Wisp does reference Wegovy in its weight care materials, and notes plainly that 'Wegovy and Wisp Inc. are separate and non-affiliated companies.' The Metabolic GLP Support Capsules at $54/month are a supplement rather than a prescription GLP-1 — do not confuse the two.

Brand-Name or Compounded?

Wisp's GLP-1 product is compounded. Its sublingual semaglutide is a compounded preparation, and Wisp maintains a dedicated FAQ entry addressing whether compounded semaglutides are FDA-approved and whether they are safe — which is more than many competitors offer.

The company also carries the standard supplement disclaimer on the page: 'These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.' And it explicitly separates itself from the brand: 'Wegovy and Wisp Inc. are separate and non-affiliated companies.'

Wisp describes its sublingual formulation as being made with a base intended to improve absorption through the lining of the mouth. This is the key clinical question with any sublingual GLP-1: absorption differs from injectable dosing, and the pivotal trials that established semaglutide's efficacy studied injections, not drops under the tongue. Wisp's own FAQ includes 'How effective is the sublingual semaglutide?' — read that answer carefully and raise it directly with the prescribing provider.

As always: compounded semaglutide is not FDA-approved, is not reviewed by the FDA for safety or effectiveness, and is not a generic version of Ozempic or Wegovy.

The Consultation Process

Eligibility

• •Wisp publishes eligibility requirements and asks you to read them before checkout, with a dedicated Treatment Eligibility section on the product page.
• •Board-certified medical providers make the clinical determination and adjust the default starting dose based on your medical history.
• •Wisp maintains a specific FAQ entry on which states can receive Weight Care Consults — state availability is limited, so check before ordering.
• •Wisp provides a BMI calculator and a related FAQ entry, though a specific published BMI threshold is not disclosed.
• •A named clinician, Dr. Shannon Chatham DO, is publicly associated with the Wisp Care Team.

Provider Involvement, Labs & Pharmacy

Shipping & Support Services

Free, discreet delivery to your door. Some Wisp products offer same-day local pharmacy pickup, though the compounded sublingual semaglutide is listed as available for delivery only. Wisp maintains FAQ entries on shipping method and whether medications require refrigeration — worth reading, since GLP-1 products are temperature-sensitive.

• •Access to the Wisp Care Team for ongoing questions
• •Free, discreet home delivery
• •Same-day pharmacy dispatch for eligible products
• •Anti-nausea support available alongside weight treatment
• •Extensive weight care FAQ covering effectiveness, safety, side effects and refrigeration
• •Optional Wisp+ membership at $30
• •15% off first order with an advertised welcome code

Fees, Cancellation & Refunds

Insurance & HSA/FSA

Pros & Cons

Who Wisp May Be Best For

• •People who will not inject and specifically want a sublingual option
• •Existing Wisp customers already using the platform for other care
• •Patients who want a fast start — 24 to 72 hours from consult request to care
• •Anyone who values a large, established platform over a newer entrant
• •Patients who want anti-nausea support bundled into the same provider relationship

Limitations

• •The single-product catalog is the core constraint. If sublingual semaglutide does not suit you — because of absorption, tolerance, or because you need a dual-action GLP-1/GIP — Wisp has nowhere else to go. Providers like Midi Health and ShedRx offer sublingual options alongside injectables and dual-action formulations.
• •Sublingual dosing deserves genuine scrutiny. Wisp is upfront enough to run an FAQ entry titled 'How effective is the sublingual semaglutide?', which tells you the question is live. The clinical evidence base for semaglutide comes from injection trials.
• •Putting the product in your cart before a clinician has seen your history is a commerce-first flow. The review does happen, and the dose is adjusted afterward, but the sequencing is worth understanding.
• •State availability being answered only inside an FAQ, rather than shown before checkout, is a poor experience for a prescription product.

Alternatives to Consider

Frequently Asked Questions

Our Verdict

Wisp is a credible operator doing one narrow thing. With 1.8 million patients and a 4.3 rating, this is not a fly-by-night compounding storefront, and its weight care FAQ is genuinely more informative than most — it addresses effectiveness, safety, refrigeration and FDA status rather than dodging them. If you will not inject and want a sublingual GLP-1 from an established platform that can have care to you within 72 hours, the proposition is clear.

But the offering is thin for the price. $225 a month buys a single compounded sublingual product with no injectable alternative, no tirzepatide, and no dual-action option. Midi Health sells sublingual GLP-1 from $164 and sublingual dual-action from $209, priced by dose, from 503B-accredited pharmacies — with insurance-covered visits on top. On the specific thing Wisp does, competitors do more for less.

We would also want the sublingual efficacy question answered directly before starting. Wisp deserves credit for raising it in its own FAQ rather than pretending it does not exist, but the fact that it needs an FAQ entry is the point: you are choosing a route of administration that the pivotal semaglutide trials did not study. Ask the provider what to expect, and go in with realistic expectations rather than assuming the drops perform like an injection.